{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T10:18:19Z","timestamp":1791368299519,"version":"4.3.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.drugalcdep.2013.12.015","type":"journal-article","created":{"date-parts":[[2014,1,4]],"date-time":"2014-01-04T02:00:20Z","timestamp":1388800820000},"page":"100-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: Modafinil, levodopa\u2013carbidopa, naltrexone"],"prefix":"10.1016","volume":"136","author":[{"given":"Joy M.","family":"Schmitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela L.","family":"Stotts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuvan S.","family":"Rathnayaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Gerard","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","article-title":"Modafinil for the treatment of cocaine dependence","volume":"104","author":"Anderson","year":"2009","journal-title":"Drug Alcohol Depend."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2013.12.015_bib0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1360-0443.2005.00983.x","article-title":"A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence","volume":"100","author":"Berger","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0015","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.drugalcdep.2010.04.006","article-title":"A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period","volume":"111","author":"Bisaga","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.drugalcdep.2005.07.009","article-title":"A randomized placebo-controlled trial of gabapentin for cocaine dependence","volume":"81","author":"Bisaga","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.drugalcdep.2004.06.007","article-title":"Utility of lead-in period in cocaine dependence pharmacotherapy trials","volume":"77","author":"Bisaga","year":"2005","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0030","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.drugalcdep.2011.05.019","article-title":"A placebo controlled trial of memantine as an adjunct to oral naltrexone for opioid dependence","volume":"119","author":"Bisaga","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0035","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1037\/1082-989X.6.4.330","article-title":"A comparison of inclusive and restrictive strategies in modern missing data procedures","volume":"6","author":"Collins","year":"2001","journal-title":"Psychol. Methods"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF02244173","article-title":"Opiate antagonists reduce cocaine but not nicotine self-administration","volume":"104","author":"Corrigall","year":"1991","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2329-6488.1000108","article-title":"Measuring outcome in the treatment of cocaine dependence","volume":"1","author":"Crits-Christoph","year":"2013","journal-title":"J. Alcohol. Drug Depend."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0050","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.npp.1300600","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"30","author":"Dackis","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0055","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"43","author":"Dackis","year":"2012","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0376-8716(02)00335-6","article-title":"Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study","volume":"70","author":"Dackis","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1037\/1064-1297.9.3.317","article-title":"Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude","volume":"9","author":"Dallery","year":"2001","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0070","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1530-0277.1996.tb01142.x","article-title":"Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer","volume":"20","author":"Del Boca","year":"1996","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0075","series-title":"Applied Missing Data Analysis (Methodology in the Social Sciences)","year":"2010"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0080","series-title":"Guidance for industry. Enrichment strategies for clinical trials to support approval of human drugs and biological products.","author":"FDA","year":"2013"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0085","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1176\/appi.ps.53.3.288","article-title":"The DSM-IV Text Revision: rationale and potential impact on clinical practice","volume":"53","author":"First","year":"2002","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0090","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.npp.1301472","article-title":"Smoked cocaine self-administration is decreased by modafinil","volume":"33","author":"Hart","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0095","series-title":"Cognitive-Behavioral Coping Skills Therapy Manual: A Clinical Research Guide for Therapists Treating Individuals with Alcohol Abuse and Dependence","year":"1992"},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2013.12.015_bib0100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1360-0443.2005.00987.x","article-title":"Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned","volume":"100","author":"Kampman","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1037\/1064-1297.10.1.10","article-title":"The brief abstinence test: effects of continued incentive availability on cocaine abstinence","volume":"10","author":"Katz","year":"2002","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ddmod.2009.04.002","article-title":"Hedonic homeostatic dysregulation as a driver of drug-seeking behavior","volume":"5","author":"Koob","year":"2008","journal-title":"Drug Discov. Today Dis. Models"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0115","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1098\/rstb.2008.0094","article-title":"Review. Neurobiological mechanisms for opponent motivational processes in addiction","volume":"363","author":"Koob","year":"2008","journal-title":"Philos. Trans. R. Soc. Lond. B: Biol. Sci."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0120","first-page":"151","article-title":"Relapse prevention. An overview of Marlatt's cognitive-behavioral model","volume":"23","author":"Larimer","year":"1999","journal-title":"Alcohol Res. Health"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0125","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/00952990600920425","article-title":"Modafinil and cocaine interactions","volume":"32","author":"Malcolm","year":"2006","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0130","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1176\/appi.ajp.2010.10050748","article-title":"Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment","volume":"168","author":"Martinez","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0135","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1755-5949.2011.00263.x","article-title":"A novel, nonbinary evaluation of success and failure reveals bupropion efficacy versus methamphetamine dependence: reanalysis of a multisite trial","volume":"18","author":"McCann","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0140","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The Fifth Edition of the Addiction Severity Index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0145","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-013-3232-4","article-title":"The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders","volume":"229","author":"Mereu","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/01.adt.0000132509.65041.bf","article-title":"Comparing measures of medication taking in a pharmacotherapy trial for cocaine dependence","volume":"3","author":"Mooney","year":"2004","journal-title":"Addict. Disord. Treat."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0155","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.drugalcdep.2006.10.011","article-title":"Safety, tolerability and efficacy of levodopa\u2013carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials","volume":"88","author":"Mooney","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0160","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.addbeh.2007.11.011","article-title":"A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence","volume":"33","author":"Pettinati","year":"2008","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0165","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0091-3057(91)90090-O","article-title":"Intracerebroventricular naltrexone treatment attenuates acquisition of intravenous cocaine self-administration in rats","volume":"40","author":"Ramsey","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0170","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.addbeh.2003.08.010","article-title":"Who gets in? Recruitment and screening processes of outpatient substance abuse trials","volume":"29","author":"Sayre","year":"2004","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0175","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/10550490903077929","article-title":"High-dose naltrexone therapy for cocaine-alcohol dependence","volume":"18","author":"Schmitz","year":"2009","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0180","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1037\/a0019195","article-title":"Contingency management and levodopa\u2013carbidopa for cocaine treatment: a comparison of three behavioral targets","volume":"18","author":"Schmitz","year":"2010","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0185","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.drugalcdep.2007.11.004","article-title":"Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform","volume":"94","author":"Schmitz","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fpsyt.2012.00077","article-title":"Combination of modafinil and d-amphetamine for the treatment of cocaine dependence: a preliminary investigation","volume":"3","author":"Schmitz","year":"2012","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0195","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0306-4603(00)00098-8","article-title":"Naltrexone and relapse prevention treatment for cocaine-dependent patients","volume":"26","author":"Schmitz","year":"2001","journal-title":"Addict. Behav."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0200","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/10550490490480982","article-title":"Treatment of cocaine-alcohol dependence with naltrexone and relapse prevention therapy","volume":"13","author":"Schmitz","year":"2004","journal-title":"Am. J. Addict."},{"issue":"Suppl. 1","key":"10.1016\/j.drugalcdep.2013.12.015_bib0205","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1360-0443.2005.00991.x","article-title":"Randomized controlled pilot trial of cabergoline, hydergine and levodopa\/carbidopa: Los Angeles Cocaine Rapid Efficacy Screening Trial (CREST)","volume":"100","author":"Shoptaw","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0210","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s002130051098","article-title":"Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude","volume":"146","author":"Silverman","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0215","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neuropharm.2012.06.021","article-title":"Cognitive enhancement as a treatment for drug addictions","volume":"64","author":"Sofuoglu","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0220","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1037\/0022-006X.69.5.858","article-title":"Motivational interviewing with cocaine-dependent patients: a pilot study","volume":"69","author":"Stotts","year":"2001","journal-title":"J. Consult. Clin. Psychol."},{"key":"10.1016\/j.drugalcdep.2013.12.015_bib0225","series-title":"Mixed Effects Models and Extensions in Ecology with R","year":"2009"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871613005310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871613005310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T13:22:17Z","timestamp":1538918537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871613005310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":45,"alternative-id":["S0376871613005310"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.12.015","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: Modafinil, levodopa\u2013carbidopa, naltrexone","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}